Evan Gomes
City University of New York
5 Papers
90 Citations
Evan Gomes is an academic researcher from City University of New York. The author has contributed to research in topics: Kinase & Programmed cell death. The author has an hindex of 5, co-authored 5 publications.
Chat about Author
Papers
The VEGFR2 and PKA pathways converge at MEK/ERK1/2 to promote survival in serum deprived neuronal cells.
TL;DR: It is suggested that PKA and VEGFR2 converge at the MEK/ERK1/2 pathway to protect serum starved neuronal cells from a caspase-dependent cell death.
32
Myc stabilization in response to estrogen and phospholipase D in MCF-7 breast cancer cells.
TL;DR: It is reported here that estrogen‐ and PLD‐induced increases in Myc expression are due to reduced turnover of Myc protein, which provides a mechanism for elevated MyC expression in hormone‐dependent and hormone‐independent breast cancer.
31
p38 MAPK as a negative regulator of VEGF/VEGFR2 signaling pathway in serum deprived human SK-N-SH neuroblastoma cells
Evan Gomes,Patricia Rockwell +1 more
TL;DR: It is shown that treatments with the p38 MAPK inhibitor, SB202190, enhanced VEGF-mediated survival in serum deprived SK-N-SH neuroblastoma cells by decreasing caspase-3/7 activation while increasing the phosphorylation of the extracellular signal-regulated kinase (ERK1/2) and Akt signaled through the V EGF receptor, VEGFR2.
28
Reactive oxygen species induced by proteasome inhibition in neuronal cells mediate mitochondrial dysfunction and a caspase-independent cell death
TL;DR: ROS induced by proteasome inhibition mediates a mitochondrial dysfunction in neuronal cells that culminates in death through caspase- and Bax-independent mechanisms, implicated ROS as a mediator of PSI-induced cytotoxicity.
Redox regulates COX-2 upregulation and cell death in the neuronal response to cadmium.
TL;DR: These findings implicate PI3-K, a flavoprotein, p38 MAPK and COX-2 in a neuronal redox-regulated pathway that mediates cadmium-induced oxidative stress.